Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

This item is discarded!Release HistoryDetailsSummary

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

Cremer, S., Pilgram, L., Berkowitsch, A., Stecher, M., Rieg, S., Shumliakivska, M., et al. (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLOS ONE, 16(10): e0258684. doi:10.1371/journal.pone.0258684.

Item is Discarded

Basic (Discarded)

Date of Discard: 2022-07-26

Comment: Dublette

Creators:
Cremer, Sebastian
Pilgram, Lisa
Berkowitsch, Alexander
Stecher, Melanie
Rieg, Siegbert
Shumliakivska, Mariana
Bojkova, Denisa
Wagner, Julian Uwe Gabriel
Aslan, Galip Servet¹
Spinner, Christoph
Luxan, Guillermo
Hanses, Frank
Dolff, Sebastian
Piepel, Christiane
Ruppert, Clemens
Guenther, Andreas
Ruthrich, Maria Madeleine
Vehreschild, Jorg Janne
Wille, Kai
Haselberger, Martina
Heuzeroth, HannoHansen, ArneEschenhagen, ThomasCinatl, JindrichCiesek, SandraDimmeler, StefanieBorgmann, StefanZeiher, Andreas more..

Affiliations:
1IMPRS, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_3242057

Dates: Published Online: 2021-10-21

Files: 0 Files

Locators: 0 Locators

version ID: item_3371028_2

Item State: Discarded

Name of Context: Publications of the MPI for Heart and Lung Research, Affiliated to: Max Planck Institute for Heart and Lung Research